A Vaccine Meets Its Promise: Success in Controlling Epidemic Meningitis in Sub-Saharan Africa

por Sambo, Luis, Chan, Margaret, Davis, Steve, Lake, Anthony, Berkley, Seth, Poonawalla, Cyrus, Elias, Christopher J.
Publicado 2015

Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Instit...

por Kulkarni, Prasad S., Socquet, Muriel, Jadhav, Suresh S., Kapre, Subhash V., LaForce, F. Marc, Poonawalla, Cyrus S.
Publicado 2015

Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure

por Kang, Gagandeep, Lakhkar, Anand, Bhamare, Chetanraj, Dharmadhikari, Abhijeet, Narwadkar, Jyoti, Kanujia, Arti, Kapse, Dhananjay, Gunale, Bhagwat, Poonawalla, Cyrus S., Kulkarni, Prasad S.
Publicado 2023

Post-marketing safety surveillance of the rotavirus vaccine in India

por Kang, Gagandeep, Lakhkar, Anand, Bhamare, Chetanraj, Dharmadhikari, Abhijeet, Narwadkar, Jyoti, Kanujia, Arti, Desai, Sajjad, Gunale, Bhagwat, Poonawalla, Cyrus S., Kulkarni, Prasad S.
Publicado 2023

A phase I clinical study to assess safety and immunogenicity of yellow fever vaccine

por Desai, Sajjad, Anil, K., Potey, Anirudha Vyankatesh, Sindhu, Y., Grappi, Silvia, Lapini, Giulia, Manney, Satyaprasad, Tyagi, Parikshit, Montomoli, Emanuele, Poonawalla, Cyrus S., Kulkarni, Prasad S.
Publicado 2022

A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults

por Kulkarni, Prasad S., Gunale, Bhagwat, Kohli, Sunil, Lalwani, Sanjay, Tripathy, Srikanth, Kar, Sonali, Raut, Sidram, Kulkarni, Praveen, Apte, Aditi, Bavdekar, Ashish, Bhalla, Hira Lal, Plested, Joyce S., Cloney-Clark, Shane, Zhu, MingZhu, Kalkeri, Raj, Pryor, Melinda, Hamilton, Stephanie, Thakar, Madhuri, Sannidhi, Ranga S., Baranwal, Punjita, Bhamare, Chetanraj, Dharmadhikari, Abhijeet, Gupta, Manish, Poonawalla, Cyrus S., Shaligram, Umesh, Kapse, Dhananjay
Publicado 2023

Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study

por Kulkarni, Prasad S., Kadam, Abhijit, Godbole, Sheela, Bhatt, Varsha, Raut, Abhishek, Kohli, Sunil, Tripathi, Santanu, Kulkarni, Praveen, Ludam, Rakhi, Prabhu, Madhav, Bavdekar, Ashish, Gogtay, Nithya J., Meshram, Sushant, Kadhiravan, Tamilarasu, Kar, Sonali, Narayana, D.H. Ashwath, Samuel, Clarence, Kulkarni, Govind, Gaidhane, Abhay, Sathyapalan, Dipu, Raut, Sidram, Hadda, Vijay, Bhalla, Hira Lal, Bhamare, Chetanraj, Dharmadhikari, Abhijeet, Plested, Joyce S., Cloney-Clarke, Shane, Zhu, Mingzhu, Pryor, Melinda, Hamilton, Stephanie, Thakar, Madhuri, Shete, Ashwini, Gautam, Manish, Gupta, Nivedita, Panda, Samiran, Shaligram, Umesh, Poonawalla, Cyrus S., Bhargava, Balram, Gunale, Bhagwat, Kapse, Dhananjay
Publicado 2023